-
PROVIDERS
TEMPUS PUBLICATIONS
Browse our latest selection of abstracts, manuscripts, and presentations.
-
LIFE SCIENCES
NEW PRODUCT
xF Monitor: Tumor uninformed treatment response monitoring (TRM) assay for RUO ctDNA detection and quantification
- PATIENTS
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
09/20/2022
Patient recruitment at the speed of science
Learn how Sermonix Pharmaceuticals partnered with Tempus and its TIME network of clinical sites to accelerate patient recruitment for a phase 2 study.
Authors
Sibel Blau, MD
President and CEO, Quality Cancer Care Alliance Network
Medical Director, Northwest Medical Specialties
Matthew Cooney, MD
Vice President, Therapeutic Development, Tempus
President and CEO, Quality Cancer Care Alliance Network
Medical Director, Northwest Medical Specialties
Matthew Cooney, MD
Vice President, Therapeutic Development, Tempus
-
11/09/2023TriHealth achieved 9X annual enrollment increase with Tempus TIME
Discover how a multi-location hospital network leveraged TIME to dramatically increase clinical trial enrollment across their oncology portfolio.
Read more -
10/17/2023Impact of multimodal data in translational science
In this panel session we spoke to Translational Scientists who have been utilizing multi-modal insights in their daily work and discussed what new information can come to light by utilizing these tools.
Watch replay -
08/18/2023
An analysis on the utility of liquid biopsy (LBx) throughout clinical development
Listen to industry leaders discuss longitudinal endpoints for disease progression, the evolving role of liquid biopsy within drug development, and the value of methylation in combination with liquid biopsy.
Watch replay